Thrombotic Risk and Immobility in Residents of Long-Term Care Facilities

Journal of the American Medical Directors Association

Volumn 11, Issue 3, 2010, Pages 211-221

  Zarowitz, Barbara J ^a   Tangalos, Eric ^b   Lefkovitz, Allen ^a   Bussey, Henry ^c   Deitelzweig, Steven ^d   Nutescu, Edith ^e   O'Shea, Terrence ^a   Resnick, Barbara ^f   Wheeler, Arthur ^g  

^a Omnicare Inc   (United States)

^b MAYO CLINIC   (United States)

^c UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^d TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^f UNIVERSITY OF MARYLAND   (United States)

^g VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

immobility; long term care; Thrombosis

Indexed keywords

AROMATASE INHIBITOR; ERYTHROID POTENTIATING FACTOR; HEMOGLOBIN; MEGESTROL ACETATE; SELECTIVE ESTROGEN RECEPTOR MODULATOR;

ARTICLE; CATHETER INFECTION; CHRONIC OBSTRUCTIVE LUNG DISEASE; DEHYDRATION; ENTERITIS; EVIDENCE BASED MEDICINE; GERIATRIC CARE; HEALTH CARE FACILITY; HEART FAILURE; HORMONE SUBSTITUTION; HUMAN; HYPERCOAGULABILITY; IMMOBILIZATION; INFECTION; LONG TERM CARE; NEOPLASM; OBESITY; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; VENOUS THROMBOEMBOLISM;

EID: 77049103154     PISSN: 15258610     EISSN: 15389375     Source Type: Journal    
DOI: 10.1016/j.jamda.2009.11.006     Document Type: Article

References (79)

1. Goldhaber S.Z. Preventing pulmonary embolism and deep vein thrombosis: A call to action for vascular medicine specialists. Thromb Haemost 5 (2007) 1607-1608
2. Heit J.A., and Cohen A.T. Anderson FAJ on behalf of the VTE Impact Assessment Group. Estimated annual number of incident and recurrent, non-fatal venous thromboembolism (VTE) events in the US. ASH Annual Meeting Abstracts 106 (2005) 910
3. Anderson Jr. F.A., Wheeler H.B., Goldberg R.J., et al. A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The Worcester DVT Study. Arch Intern Med 151 (1991) 933-938
4. Heit J.A. Venous thromboembolism: Disease burden, outcomes and risk factors. J Thromb Haemost 3 (2005) 1611-1617
5. White R.H. The epidemiology of venous thromboembolism. Circulation 107 (2003) 14-18
6. Wan H., Sengupta M., Velkoff V.A., and DeBarros K.A. US Census Bureau, Current Population Reports, P23-209, 65+ in the United States: 2005 (2005), US Government Printing Office, Washington, DC. http://www.census.gov/prod/2006pubs/p23-209.pdf Accessed March 4, 2009
7. Leibson C.L., Petterson T.M., Bailey K.R., et al. Risk factors for venous thromboembolism in nursing home residents. Mayo Clin Proc 83 (2008) 151-157
8. Gomes J.P., Shaheen W.H., Truong S.V., et al. Incidence of venous thromboembolic events among nursing home residents. J Gen Intern Med 18 (2003) 934-936
9. Weill-Engerer S., Meaume S., Lahlou A., et al. Risk factors for deep vein thrombosis in inpatients aged 65 and older: A case-control multicenter study. J Am Geriatr Soc 52 (2004) 1299-1304
10. Geerts W.H., Bergquvist D., Pineo G.F., et al. Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th edition). Chest 133 (2008) 381S-453S. http://chestjournal.org/cgi/content/abstract/133/6_suppl/381S Accessed August 10, 2009
11. Couturaud F., Lacut K., Leroyer C., and Mottier D. Assessment of the risk and prophylactic treatment of venous thromboembolism in the elderly. Pathophysiol Haemost Thromb 33 (2003/2004) 362-365
12. Jacobs I.G. Prophylactic anticoagulation for venous thromboembolic disease in geriatric patients. J Am Geriatr Soc 51 (2003) 1472-1478
13. Bosson J.L., Labarere J., Barrellier M.T., et al. [Practice guidelines for the prevention of venous thromboembolism in elderly patients hospitalized in subacute care and rehabilitation facilities.]. J Mal Vasc 28 (2003) 209-218 French
14. Yeznach Wick J. Treat VTE in long-term care. Caring for the Ages 5 (2004) 38-48
15. Sloane P.D., Gruber-Baldini A.L., Zimmerman S., et al. Medication undertreatment in assisted living facilities. Arch Intern Med 164 (2004) 2031-2037
16. Amin A., Stemkowski S., Lin J., and Yang G. Thromboprophylaxis rates in US medical centers: Success or failure?. J Thromb Haemost 5 (2007) 1610-1616
17. Goldhaber S.Z., and Tapson V.F. A prospective registry of 5,441 patients with ultrasound-confirmed deep vein thrombosis. Am J Cardiol 93 (2004) 259-262
18. Kucher N., Tapson V.F., and Goldhaber S.Z. DVT FREE Steering Committee. Risk factors associated with symptomatic pulmonary embolism in a large cohort of deep vein thrombosis patients. Thromb Haemost 93 (2005) 494-498
19. Tapson V.F., Decousus H., Pini M., et al. Venous thromboembolism prophylaxis in acutely ill hospitalized medical patients: Findings from the International Medical Prevention Registry on Venous Thromboembolism. Chest 132 (2007) 936-945
20. Piazza G., Seddighzadeh A., Goldhaber S.Z., et al. Heart failure in patients with deep vein thrombosis. Am J Cardiol 101 (2008) 1056-1059
21. Shetty R., Seddighzadeh A., Piazza G., et al. Chronic obstructive pulmonary disease and deep vein thrombosis: A prevalent combination. J Thromb Thrombolysis 26 (2008) 35-40
22. Semana M.M., Dahl L.E., Quinlan D.J., et al. Quantification of risk factors for venous thromboembolism: A preliminary study for the development of a risk assessment tool. Haematologica 88 (2003) 1410-1421
23. Arcelus JI, Caprini JA, Monreal M, et al. The management and outcome of acute venous thromboembolism: A prospective registry including 4011 patients. J Vasc Surg:916-922, and algorithm available at: http://www.venousdisease.com/riskfactors.html. Accessed December 10, 2009.
24. Van Tulder M., Furlan A., Bombardier C., and Bouter L. Editorial Board of the Cochrane Collaboration Back Review Group. Updated method guidelines for systematic reviews in the Cochrane Collaboration Back Review Group. Spine 28 (2003) 1290-1299
25. Dalkey N., Brown B., and Cochran S. The Delphi Method, III: Use of self ratings to improve group estimates (November 1969), Rand Corporation, Santa Monica, CA Publication RM-6115-PR
26. Grady D., Wenger N.K., Herringto D., et al. Postmenopausal hormone therapy increases risk for venous thromboembolic disease (HERS). Ann Intern Med 132 (2000) 689-696
27. Hull R.D. Extended-duration thromboprophylaxis in acutely ill medical patients with recent reduced mobility (EXCLAIM). J Thromb Thrombolysis 22 (2006) 31-36
28. PREVENT. Investigators. Rationale and design of LMWH in preventing clinically important DVT in medical patients. PREVENT study. Vasc Med 7 (2002) 269-273
29. Ray J.G., Kearon C., Yi Q., et al. Homocysteine-lowering therapy and risk for venous thromboembolism. Ann Intern Med 146 (2007) 761-767
30. Ageno W., Prandoni P., Romualdi E., et al. The metabolic syndrome and the risk of venous thrombosis: A case-control study. J Thromb Haemost 4 (2006) 1914-1918
31. Aguilar C., Martinez A., Martinez A., et al. Diagnostic value of D-dimer in patients with a moderate pretest probability of DVT. Br J Haematol 118 (2002) 275-277
32. Alikhan R., Cohen A.T., Combe S., et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness. Arch Intern Med 164 (2004) 963-968
33. Baglin T., Palmer C.R., Luddington R., et al. Unprovoked recurrent venous thrombosis: Prediction by D-dimer and clinical risk factors. J Thromb Haemost 6 (2008) 577-582
34. Baglin T., Luddington R., Brown K., et al. High risk of recurrent venous thromboembolism in men. J Thromb Haemost 2 (2004) 2152-2155
35. Bjørnarå B.T., Gudmundsen T.E., and Dahl O.E. Frequency and timing of clinical venous thromboembolism after major joint surgery. J Bone Joint Surg [Br] 88-B (2006) 386-391
36. Blom J.W., Vanderschoot J.P.M., Oostindier M.J., et al. Incidence of venous thrombosis in a large cohort of 66 329 cancer patients: Results of a record linkage study. J Thromb Haemost 4 (2006) 529-535
37. Bosson J.L., Labarere J., Sevestre M.A., et al. Deep vein thrombosis in elderly patients hospitalized in subacute care facilities. Arch Intern Med 163 (2003) 2613-2618
38. Canonico M., Oger E., Conard J., et al. Obesity and risk of venous thromboembolism among postmenopausal women (The ESTHER Study). J Thromb Haemost 4 (2006) 1259-1265
39. Cosmi B., Legnani C., Cini M., et al. D-dimer levels in combination with residual venous obstruction and the risk of recurrence after anticoagulation withdrawal for a first idiopathic deep vein thrombosis. Thromb Haemost 94 (2005) 969-974
40. Curb J.D., Prentice R.L., Bray P.F., et al. Venous thrombosis and conjugated equine estrogen in women without a uterus (WHI). Arch Intern Med 166 (2006) 772-780
41. Cushman M., Folsom A.R., Wang L., et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood 101 (2003) 1243-1248
42. Douketis J.D., Crowther M.A., Foster G.A., et al. Does the location of thrombosis determine the risk of disease recurrence in patients with proximal deep vein thrombosis?. Am J Med 110 (2001) 515-519
43. Edelsberg J., Hagiwara M., Taneja C., et al. Risk of venous thromboembolism among hospitalized medically ill patients. Am J Health-Syst Pharm 63 (2006) S16-S22
44. Folsom A.R., Boland L.L., Cushman M., et al. Frailty and risk of venous thromboembolism in older adults. J Gerontol 62A (2007) 79-82
45. Gallerani M., Boari B., de Toma D., et al. Seasonal variation in the occurrence of deep vein thrombosis. Med Sci Monit 10 (2004) CR191-CR196
46. Gangireddy C., Rectenwald J.R., Upchurch G.R., et al. Risk factors and clinical impact of postoperative symptomatic venous thromboembolism. J Vasc Surg 45 (2007) 335-342
47. Gatt M.E., Paltiel O., and Bursztyn M. Is prolonged immobilization a risk factor for symptomatic venous thromboembolism in elderly bedridden patients?. Thromb Haemost 91 (2004) 538-543
48. Haas S.K., Hach-Wunderle V., Mader F.H., et al. An evaluation of venous thromboembolism risk in acutely 111 medical patients immobilized at home: The AT-HOME Study. Clin Appl Thromb Hemost 13 (2007) 7-13
49. Hansson P.O., Sörbo J., and Eriksson H. Recurrent venous thromboembolism after deep vein thrombosis. Arch Intern Med 160 (2000) 769-774
50. Heit J.A., Mohr D.N., Silverstein M.D., et al. Predictors of recurrence after deep vein thrombosis and pulmonary embolism. Arch Intern Med 160 (2000) 761-768
51. Heit J.A., Silverstein M.D., Mohr D.N., et al. The epidemiology of venous thromboembolism in the community. Thromb Haemost 86 (2001) 452-463
52. Howell M.D., Geraci J.M., and Knowlton A.A. Congestive heart failure and outpatient risk of venous thromboembolism. J Clin Epidemiol 54 (2001) 810-816
53. Huerta C., Johansson S., Wallander M.A., et al. Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the UK. Arch Intern Med 167 (2007) 935-943
54. Lawall H., Hoffmanns W., Hoffmanns P., et al. Prevalence of deep vein thrombosis in non-surgical patients at hospital admission. Thromb Haemost 98 (2007) 765-770
55. Mantilla C.B., Horlocker T.T., Schroeder D.R., et al. Risk factors for clinically relevant pulmonary embolism and deep vein thrombosis in patients undergoing primary hip or knee arthroplasty. Anesthesiol 99 (2003) 552-560
56. Palareti G., Legnani C., Cosmi B., et al. Poor anticoagulation quality in the first 3 months after unprovoked venous thromboembolism is a risk factor for long-term recurrence. J Thromb Haemost 3 (2005) 955-961
57. Palareti G., Legnani C., Cosmi B., et al. Risk of venous thromboembolism recurrence. Thromb Haemost 87 (2002) 7-12
58. Piazza G., Seddighzadeh A., and Goldhaber S.Z. Deep vein thrombosis in the elderly. Clin Ap Thromb Hemost 14 (2008) 393-398
59. Proctor M.C., Wainess R.M., Henke P.K., et al. Venous thromboembolism: Regional differences in the nationwide inpatient sample, 1993 to 2000. Vascular 12 (2004) 374-380
60. Ray J.G., Mamdani M., Tsuyuki R.T., et al. Use of statins and the subsequent development of DVT. Arch Intern Med 161 (2001) 1405-1410
61. Ray J.G., Mamdani M., and Yeo E.L. Antipsychotic and antidepressant drug use in the elderly and the risk of VTE. Thromb Haemost 88 (2002) 205-209
62. Sellier E., Labarere J., Sevestre M.A., et al. Risk factors for deep vein thrombosis in older patients: a multicenter study with systematic compression ultrasonography in postacute care facilities in France. J Am Geriatr Soc 56 (2008) 224-230
63. Smeeth L., Cook C., Thomas S., et al. Risk of DVT and PE after acute infection in a community setting. Lancet 367 (2006) 1075-1079
64. Spencer F.A., Emery C., Lessard D., et al. Upper extremity deep vein thrombosis: A community-based perspective. Am J Med 120 (2007) 678-684
65. van Stralen K.J., Doggen C.J.M., Lumley T., et al. The relationship between exercise and risk of VT in elderly people. J Am Geriatr Soc 56 (2008) 517-522
66. White R.H., Zhou H., Murin S., et al. Effect of ethnicity and gender on the incidence of venous thromboembolism in a diverse population in California in 1996. Thromb Haemost 93 (2005) 298-305
67. Zakai N.A., Wright J., and Cushman M. Risk factors for venous thromboembolism in medical inpatients: Validation of a thrombosis risk score. J Thromb Haemost 2 (2004) 2156-2161
68. Bosson J.L. A prospective observational study of a cohort of outpatients with an acute medical event and reduced mobility. J Int Med 260 (2006) 168-176
69. Cohen A.T., Turpie A.G.G., Leizorovicz A., et al. Thromboprophylaxis with dalteparin in medical patients: Which patients benefit?. Vascular Medicine 12 (2007) 123-128
70. Duggan C. Inherited and acquired risk factors for VTE disease among women taking tamoxifen to prevent breast cancer. J Clin Oncol 21 (2003) 3588-3593
71. Montreal M. Fatal PE and fatal bleeding in cancer patients with VTE; findings from RIETE registry. J Thromb Haemost 4 (2006) 1950-1956
72. Steen H.E. Thrombosis associated with physical restraints. Acta Psychiatr Scand 103 (2001) 73-76
73. De Freitas G.R., and Nagayama M. Deep venous thrombosis after intracerebral hemorrhage, gender and ethnicity: A challenge for therapeutic approaches. Cerebrovasc Dis 27 (2009) 320-321
74. Katz S., and Akpom C.A. 12. Index of ADL. Med Care 14 (1976) 116-118
75. Podsiadlo D., and Richardson S. The Timed "Up & Go": A test of basic functional mobility for frail elderly persons. J Am Geriatr Soc 39 (1991) 142-148
76. Valderrama A., Del Castrillo J., DiazGranados C.A., et al. Deep vein thrombosis in chronically bedridden elderly individuals. J Am Geriatr Soc 54 (2006) 866-867
77. Giannelli S.V., Patel K.V., Windham G.B., et al. Magnitude of underascertainment of impaired kidney function in older adults with normal serum creatinine. J Am Geriatr Soc 55 (2007) 816-823
78. Schulman S., Beyth R.J., Kearon C., and Levine M.N. Hemorrhagic complications of anticoagulant and thrombolytic treatment: American College of Chest Physicians Evidence-based clinical practice guidelines. (8th Edition) Chest 133 (2008) 257S-298S
79. Hirsh J., Guyatt G., Albers G.W., et al. Antithrombotic and thrombolytic therapy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. (8th Edition) Chest 133 (2008) 110S-112S